Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Sanofi has appointed Anne C. Beal, MD, MPH, to a newly created position of chief patient officer.    "The appointment of a Chief Patient Officer at Sanofi, the first for a top 10 biopharmaceutical company, shows our commitment...

Merck & Co. has appointed Robert M. Davis, 47, as executive vice-president and chief financial officer, effective April 23, 2014. Davis, who will also oversee corporate strategy and corporate business development, will succeed Peter...

Pfizer reports that FDA has approved over-the-counter Nexium® 24HR (exomeprazole 20 mg), a drug to treat heartburn and gastroesophageal reflux disease. Pfizer acquired exclusive global rights to market non-prescription Nexium from...

Bayer HealthCare will invest around EUR 100 million ($138 million) to increase the production capacity of its plant in Beijing, China, in preparation for further demand of its products in the country. A respective agreement was...

GlaxoSmithKline (GSK) Consumer Healthcare is voluntarily recalling all alli® weight loss products from the United States and Puerto Rico retailers as the company believes that some packages of the product were tampered with and may...

Baxter International Inc. has announced plans to create two separate, independent global healthcare companies:one focused on developing and marketing biopharmaceuticals and the other on medical products.  "Baxter has an established history...

GlaxoSmithKline (GSK) has been granted marketing authorization by the European Commission for its once-weekly diabetes treatment, Eperzan® (albiglutide).  Eperzan is indicated for the treatment of Type 2 diabetes mellitus in adults, to...

AstraZeneca today announced it has completed the purchase of Sumitomo Chemical's remaining shares in AstraZeneca K.K., the company's Japanese subsidiary. The purchase was valued at approximately JPY10 billion ($102 million) and gives...